TY - JOUR
T1 - Ultrarapid opiate detoxification
T2 - A review
AU - Kaye, Alan D.
AU - Gevirtz, Clifford
AU - Bosscher, Hemmo A.
AU - Duke, Joe B.
AU - Frost, Elizabeth A.M.
AU - Richards, Todd A.
AU - Fields, Aaron M.
PY - 2003
Y1 - 2003
N2 - Purpose: This review on ultrarapid detoxification examines the pharmacology, techniques, and efficacy of this potentially promising technique and contrasts it with conventional treatment modalities. Source: The information found here is derived from experiences at the Texas Tech University, government reports, and peer reviewed journals. Principal findings: Incidence and prevalence of heroin use is on the rise. Social and treatment costs suggest that this problem is staggering. Approximately 400,000 patients are enrolled in or are actively seeking methadone therapy. While many of these individuals want to undergo detoxification, traditional techniques, including methadone tapering are usually unsuccessful. The withdrawal syndrome is extremely unpleasant, may be fatal, and deters patients from completing the detoxification process. Uttrarapid detoxification entails general anesthesia in conjunction with large boluses of narcotic antagonists. This combination allows the individual to completely withdraw from the opiate without suffering the discomfort of the withdrawal syndrome. Unless performed properly, this procedure can be dangerous due to the sympathetic outflow. However, with proper support, this danger can be mitigated. Conclusion: Ultrarapid opiate detoxification, performed under the proper circumstances, is associated with few adverse events and is relatively comfortable for patients who seek treatment for their addition.
AB - Purpose: This review on ultrarapid detoxification examines the pharmacology, techniques, and efficacy of this potentially promising technique and contrasts it with conventional treatment modalities. Source: The information found here is derived from experiences at the Texas Tech University, government reports, and peer reviewed journals. Principal findings: Incidence and prevalence of heroin use is on the rise. Social and treatment costs suggest that this problem is staggering. Approximately 400,000 patients are enrolled in or are actively seeking methadone therapy. While many of these individuals want to undergo detoxification, traditional techniques, including methadone tapering are usually unsuccessful. The withdrawal syndrome is extremely unpleasant, may be fatal, and deters patients from completing the detoxification process. Uttrarapid detoxification entails general anesthesia in conjunction with large boluses of narcotic antagonists. This combination allows the individual to completely withdraw from the opiate without suffering the discomfort of the withdrawal syndrome. Unless performed properly, this procedure can be dangerous due to the sympathetic outflow. However, with proper support, this danger can be mitigated. Conclusion: Ultrarapid opiate detoxification, performed under the proper circumstances, is associated with few adverse events and is relatively comfortable for patients who seek treatment for their addition.
UR - https://www.scopus.com/pages/publications/0142242300
U2 - 10.1007/BF03018708
DO - 10.1007/BF03018708
M3 - Review article
C2 - 12944440
AN - SCOPUS:0142242300
SN - 0832-610X
VL - 50
SP - 663
EP - 671
JO - Canadian Journal of Anaesthesia
JF - Canadian Journal of Anaesthesia
IS - 7
ER -